2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
- Andrzej Bienczak, Adrian Cook, Lubbe Wiesner, Veronica Mulenga, Cissy Kityo, Addy Kekitiinwa, A. Sarah Walker, Andrew Owen, Diana M. Gibb, David Burger, Helen McIlleron, Paolo Denti. (2017) Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African children, Journal of Antimicrobial Chemotherapy, Volume 72, Issue 1, January 2017, Pages 190–199, https://doi.org/10.1093/jac/dkw388
- Naïm Bouazza, Tim R. Cressey, Frantz Foissac, Andrzej Bienczak, Paolo Denti, Helen McIlleron, David Burger, Martina Penazzato, Marc Lallemant, Edmund V. Capparelli, Jean-Marc Treluyer, Saïk Urien. (2017) Optimization of the strength of the efavirenz/lamivudine/abacavir fixed-dose combination for paediatric patients, Journal of Antimicrobial Chemotherapy, Volume 72, Issue 2, February 2017, Pages 490–495, https://doi.org/10.1093/jac/dkw444
- Naidoo, A., Ramsuran, V., Chirehwa, M., Denti, P., McIlleron, H., Naidoo, K., Yende-Zuma, N., Singh, R., Ngcapu, S., Chaudhry, M., Pepper, M. S., & Padayatchi, N. (2017). Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis. Pharmacogenomics, 19(1), 17–29. https://doi.org/10.2217/pgs-2017-0144
- de Kock, M., Tarning, J., Barnes, K. I., & Denti, P. (2017). Response to “Lactation Status and Studies of Pyrimethamine Pharmacokinetics in Pregnancy.” CPT: Pharmacometrics & Systems Pharmacology, 6(11), 731. https://doi.org/10.1002/psp4.12256
- Rockwood, N., Pasipanodya, J. G., Denti, P., Sirgel, F., Lesosky, M., Gumbo, T., Meintjes, G., McIlleron, H., & Wilkinson, R. J. (2017). Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis. Clinical Infectious Diseases, 64(10), 1350–1359. https://doi.org/10.1093/cid/cix158
- Naidoo, A., Chirehwa, M., McIlleron, H., Naidoo, K., Essack, S., Yende-Zuma, N., Kimba-Phongi, E., Adamson, J., Govender, K., Padayatchi, N., & Denti, P. (2017). Effect of rifampicin and efavirenz on moxifloxacin concentrations when co-administered in patients with drug-susceptible TB. Journal of Antimicrobial Chemotherapy, 72(5), 1441–1449. https://doi.org/10.1093/jac/dkx004
- McIlleron, H., Denti, P., Cohn, S., Mashabela, F., Hoffmann, J. D., Shembe, S., Msandiwa, R., Wiesner, L., Velaphi, S., Lala, S. G., Chaisson, R. E., Martinson, N., Dooley, K. E., & Team, on behalf of the T. S. (2017). Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants. Journal of Antimicrobial Chemotherapy, 72(7), 2028–2034. https://doi.org/10.1093/jac/dkx112
- Singh, K., Okombo, J., Brunschwig, C., Ndubi, F., Barnard, L., Wilkinson, C., Njogu, P. M., Njoroge, M., Laing, L., Machado, M., Prudêncio, M., Reader, J., Botha, M., Nondaba, S., Birkholtz, L. M., Lauterbach, S., Churchyard, A., Coetzer, T. L., Burrows, J. N., Clive Yeates, Paolo Denti, Lubbe Wiesner, Timothy J. Egan, Sergio Wittlin, Chibale, K. (2017). Antimalarial Pyrido[1,2-a]benzimidazoles: Lead Optimization, Parasite Life Cycle Stage Profile, Mechanistic Evaluation, Killing Kinetics, and in Vivo Oral Efficacy in a Mouse Model. Journal of Medicinal Chemistry, 60(4), 1432–1448. https://doi.org/10.1021/acs.jmedchem.6b01641